Experiments proved that down-regulating DNMT1 to reduce the methylation level of CpG in NANOG promoter can enhance the CSC capability of tumor cells, which is confirmed as an indicator of the conversion of non-CSCs to CSCs [145]. The gene discussed is NANOG; the disease is neoplasm.